Dalton Transactions · 2023 · 13 citations · 35 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyCancer NanomedicineCancer Stem Cell BiologyCancer Stem CellsCoordination ChemistryNanomedicineTransition Metal ComplexesCell Death In CancerMammary Stem Cell ActivityReactive Oxygen Species GenerationReactive Oxygen Species Injury
-toluene sulfonamide-bearing copper(II)-terpyridine complex 1 is 6-8-fold more potent towards breast CSCs than salinomycin (an established anti-CSC agent) and cisplatin (a metal-based anticancer drug). The copper(II)-terpyridine complex 1 also reduces the formation, size, and viability of three-dimensionally cultured mammospheres, to a similar or better extent than salinomycin and cisplatin. Mechanistic studies show that 1 successfully enters breast CSCs, generates intracellular ROS at short exposure times, partially induces endoplasmic reticulum stress, and triggers apoptosis. To the best of our knowledge, this is the first study to investigate the anti-breast CSC properties of copper(II)-terpyridine complexes.
35
A short history of<i>SHELX</i>
George M. Sheldrick · Acta Crystallographica Section A Foundations of Crystallography · 2007 · 87.4K citations · Full text
Modern Nutrition in Health and Disease
Noel W. Solomons · American Journal of Clinical Nutrition · 1994 · 1.7K citations